These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8082522)

  • 1. Evaluation of the costs to Medicare of covering therapeutic shoes for diabetic patients.
    Wooldridge J; Moreno L
    Diabetes Care; 1994 Jun; 17(6):541-7. PubMed ID: 8082522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing diabetic foot disease: lessons from the Medicare therapeutic shoe demonstration.
    Wooldridge J; Bergeron J; Thornton C
    Am J Public Health; 1996 Jul; 86(7):935-8. PubMed ID: 8669516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Therapeutic Shoe Bill: Medicare coverage for prescription footwear for diabetic patients.
    Janisse DJ
    Foot Ankle Int; 2005 Jan; 26(1):42-5. PubMed ID: 15680118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the therapeutic footwear benefit among diabetic medicare beneficiaries in three states, 1995.
    Sugarman JR; Reiber GE; Baumgardner G; Prela CM; Lowery J
    Diabetes Care; 1998 May; 21(5):777-81. PubMed ID: 9589239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Orthopaedic Foot and Ankle Society shoe survey of diabetic patients.
    Pinzur MS; Shields NN; Goelitz B; Slovenkai M; Kaye R; Ross SD; Suri M
    Foot Ankle Int; 1999 Nov; 20(11):703-7. PubMed ID: 10582845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational brochures increase the number of medicare-eligible persons with diabetes making therapeutic footwear claims.
    LeMaster JW; Sugarman JR; Baumgardner G; Reiber GE
    Diabetes Care; 2003 Jun; 26(6):1679-84. PubMed ID: 12766093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients.
    Rizzo L; Tedeschi A; Fallani E; Coppelli A; Vallini V; Iacopi E; Piaggesi A
    Int J Low Extrem Wounds; 2012 Mar; 11(1):59-64. PubMed ID: 22336901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers.
    Carls GS; Gibson TB; Driver VR; Wrobel JS; Garoufalis MG; Defrancis RR; Wang S; Bagalman JE; Christina JR
    J Am Podiatr Med Assoc; 2011; 101(2):93-115. PubMed ID: 21406693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Utilization and Expenditures for Medicare Beneficiaries in Patient-centered Medical Homes: Findings From the Multi-Payer Advanced Primary Care Practice Demonstration.
    Nichols DE; Haber SG; Romaire MA; Wensky SG;
    Med Care; 2018 Sep; 56(9):775-783. PubMed ID: 30052548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Expanded Coverage for Chiropractic Services on Medicare Costs in a CMS Demonstration.
    Stason WB; Ritter GA; Martin T; Prottas J; Tompkins C; Shepard DS
    PLoS One; 2016; 11(2):e0147959. PubMed ID: 26928221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.
    Krop JS; Powe NR; Weller WE; Shaffer TJ; Saudek CD; Anderson GF
    Diabetes Care; 1998 May; 21(5):747-52. PubMed ID: 9589235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and cost of pneumonia in medicare beneficiaries.
    Thomas CP; Ryan M; Chapman JD; Stason WB; Tompkins CP; Suaya JA; Polsky D; Mannino DM; Shepard DS
    Chest; 2012 Oct; 142(4):973-981. PubMed ID: 22406959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996.
    Krop JS; Saudek CD; Weller WE; Powe NR; Shaffer T; Anderson GF
    Diabetes Care; 1999 Oct; 22(10):1660-6. PubMed ID: 10526731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Medicare Could Provide Dental, Vision, and Hearing Care for Beneficiaries.
    Willink A; Shoen C; Davis K
    Issue Brief (Commonw Fund); 2018 Jan; 2018():1-12. PubMed ID: 29345890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.